Indeed, CRH acted on the ovarian cancer cells OvCa3 and A2780, through CRHR1, to upregulate the expression of FasL and thus potentiate the ability of the cells to induce Fas-mediated apoptosis of activated PBL. Here, FAS is linked to ovarian cancer.